Crosstalk between oncolytic viruses and autophagy in cancer therapy

Area of Science:

• Oncology
• Virology
• Cellular Biology

Background:

• Oncolytic viruses are engineered or naturally occurring viruses that selectively infect and lyse cancer cells.
• These viruses also stimulate anti-tumor immune responses by releasing tumor antigens and danger signals.
• Autophagy, a cellular degradation process, plays a complex role in the efficacy of oncolytic virus therapy.

Purpose of the Study:

• To review current oncolytic viruses in clinical trials.
• To elucidate the dual role of autophagy in oncolytic virotherapy.
• To discuss the interplay between oncolytic viruses and autophagy for enhanced cancer treatment.

Main Methods:

• Literature review of oncolytic viruses and autophagy mechanisms.
• Analysis of preclinical and clinical data on oncolytic virus therapy.
• Discussion of the molecular interactions between viruses and the autophagy pathway.

Main Results:

• Oncolytic viruses demonstrate selective tumor cell killing and immune stimulation.
• Autophagy can promote oncolytic virus replication and enhance anti-tumor immunity.
• Conversely, autophagy may also support tumor cell survival, reducing oncolytic virus efficacy.

Conclusions:

• The interaction between oncolytic viruses and autophagy is critical for therapeutic outcomes.
• Modulating autophagy presents a potential strategy to optimize oncolytic virotherapy.
• Further research into combined oncolytic virus and autophagy-targeting therapies is warranted.